• Molecular NameChloroquine
  • SynonymChloraquine; Chlorochine; Chloroquina; Chloroquine Phosphate; Chloroquinium; Chlorquin; Clorochina; Hydroxychloroquine Sulfate
  • Weight319.88
  • Drugbank_IDDB00608
  • ACS_NO54-05-7
  • Show 3D model
  • LogP (experiment)4.474
  • LogP (predicted, AB/LogP v2.0)4.67
  • pka8.4, 10.8
  • LogD (pH=7, predicted)0.58
  • Solubility (experiment)0.0106 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-1.27
  • LogSw (predicted, AB/LogsW2.0)0.01
  • Sw (mg/ml) (predicted, ACD/Labs)0.03
  • No.of HBond Donors0
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds8
  • TPSA19.37
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA 4-aminoquinoline drug used in the treatment or prevention of malaria.
  • Absorption_value100.0
  • Absorption (description)Rapidly absorbed after oral administration and widely distributed into body tissues.
  • Caco_2N/A
  • Bioavailability80.0
  • Protein binding54.7
  • Volume of distribution (VD)132~261 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)Plasma: whole blood ratio, about 0.3.
  • MetabollsmMetabolic reactions include N-dealkylation and deamination followed by conjugation, possibly with glucuronic acid, of the carboxylic acid metabolites; the metabolites include monodesethyl- and didesethylchloroquine, 4-(7-chloroquinol-4-ylamino)pentan-1-ol, and 4-(7-chloroquinol-4-ylamino)pentanoic acid and its conjugate.
  • Half life10~24 days
  • ExcretionChloroquine is excreted slowly and may persist in the tissues for prolonged periods; about 55% is excreted in the urine and about 10% is eliminated in the faeces in 90 days following therapy with 310 mg of the phosphate daily for 14 days; the urinary excretion of unchanged drug is dependent upon urinary pH and larger amounts are excreted in acid urine than in alkaline urine; of the material excreted in the urine, about 70% is unchanged, 23% is monodesethylchloroquine, 1 to 2% is didesethylchloroquine and an unidentified metabolite, and 1 to 2% is conjugated carboxylic acid metabolites. Chloroquine and its monodesethyl metabolite are both distributed into breast milk.
  • Urinary Excretion52~58
  • Clerance3.7 ml/min/kg (after IV administration)
  • ToxicityDoses as low as 1 g have caused deaths in children and fatalities have occurred in adults after the ingestion of 3 to 44 g. Plasma concentrations greater than 0.6 mg/L may produce toxic effects and concentrations greater than 3 mg/L may be fatal.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A